Webinar: Advantages bringing early phase trials to North America

Watch Altasciences’ on-demand webinar to learn the key advantages and differences of conducting early phase clinical trials in North America.

In this complimentary webinar, you’ll discover the benefits of conducting FIH trials in Canada, including quicker regulatory approvals.

You will learn about:

  • Ensuring timely FIH clinical trials when planning your early phase drug development strategy
  • Utilizing foreign clinical trials for U.S. FDA drug submissions and approvals
  • Differences in the quality and nonclinical data submission requirements to gain EMA, FDA, and Health Canada approval to conduct FIH Phase I trials.